Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-22

Clinical Trial Update: Amlodipine Prevents Morning Blood Pressure Surge Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated amlodipine for preventing morning blood pressure surge in patients with hypertension. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Hypertension | Phase 4 | Status: COMPLETED